Skip to content
AZBio Logo
  • Members
    • Member Login
    • AZBio Member Directory
    • Join AZBio
      • Membership Application
    • Save with AZBio Purchasing Power
    • Support AZBio
  • AZBio News
    • Voice of the Patient
    • Resources for Media
  • Events
    • AZ Bioscience Week 2025
    • AZBio Awards 2025
    • AZBW 2024 Recap
  • Advocacy
    • Legislative Watch List
    • Request to Speak Instructions
    • Arizona Congressional Delegation
    • Congressional Calendar
  • Resources
    • AZBio Career Center
    • Infrastructure
    • Clinical Trials in Arizona
    • AZBioPEERS
    • AZBio PEERS Mentoring Program
    • AZAdvances Talent – Internship Program
    • Arizona BioMap
    • Resource Library
  • About
    • AZBio Staff
    • AZBio Board of Directors
    • Arizona Innovation
    • Arizona Bioindustry Fact Sheet
    • AZBio History
  • Menu

Category Archives: Advocacy and Regulations

Update – Proposed Continuing Resolution in the U.S. House and Medical Device Tax Suspension

Posted on Wed/17/JanuaryWed/17/January by AZBio

The countdown clock is ticking on the status of federal funding and the end of the two-year suspension of the medical device tax.  First payments on the medical device tax are due to be made in just 12 days.Continue reading→

Draft Legislation for User Fee Reauthorization Released on April 14, 2017

Posted on Mon/17/AprilMon/17/April by AZBio

On April 14, 2017, the leaders of the Senate and House health committees  released a discussion draft of bipartisan legislation reauthorizing the Food and Drug Administration user fee agreements. Continue reading→

Sharing Arizona Bioindustry News in Washington DC

Posted on Sat/4/MarchSat/18/March by AZBio

AZBio delivered data on life-changing innovation and the economic impact of Arizona’s life sciences industry to Arizona’s Congressional Delegation last week in meetings with 10 of Arizona’s 11 Congressional offices. 

Continue reading→

Understanding Gov. Ducey’s $1 billion university research infrastructure plan

Posted on Thu/2/FebruaryThu/16/February by AZBio
 

Building on Success for a Better Arizona – Your Letter Can Make a Difference – Click Here to Learn More

 

Continue reading→

Bill to Streamline CMS’s Process for Breakthrough Technologies Introduced in the US Senate

Posted on Fri/27/MayFri/27/May by AZBio

The Ensuring Patient Access to Critical Breakthrough Products Act, will help bridge a gap between FDA and CMS and improve patient access to breakthrough medical technologies for serious illnesses, S. 2998, to expedite CMS decision-making for innovative medical technologies.Continue reading→

Arizona Governor Ducey Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines

Posted on Mon/23/MayMon/23/May by AZBio

Communication Important for Patients and PhysiciansContinue reading→

Arizonans advocating for a more accurate test for Lyme Disease

Posted on Wed/18/MayWed/18/May by AZBio

Focus On Lyme executive director to speak at Capitol Hill science forum. Arizona-based group advocates for a definitive test for Lyme disease being developed by TGenContinue reading→

AZBio Watch List for April 25 2016

Posted on Mon/25/AprilMon/25/April by AZBio

Learn more about the bills AZBio is tracking at the Arizona Legislature
Continue reading→

HB 2310- Getting Ready for Biosimilars in Arizona

Posted on Mon/1/FebruaryFri/25/March by AZBio

The FDA approved the first biosimilar in the U.S. in March of 2015 with more expected to be approved in 2016.  Now, on a state by state basis, the laws that govern how these new therapies can be dispensed are being updated.   Arizona has the opportunity to do so in 2016 with HB 2310 sponsored by Dr. Regina Cobb, Vice Chairman of the House Health Committee.Continue reading→

Congress Suspends The Medical Device Tax for Two Years

Posted on Mon/21/DecemberMon/21/December by AZBio

Medical device innovators got good news on December 18th as  Congress passed a two-year moratorium on a tax the industry said was limiting its growth. Companies and industry backers in Arizona and around the country have worked for years to repeal the 2.3 percent tax on revenue from medical device sales. Continue reading→

Post navigation

« Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 21 Next »

Blog Categories

Upcoming Events

  • RESI Boston June 2025
            Jun 16, 2025 -
  • AZBioPEERS: Life Science Workforce Outlooks
            Jun 24, 2025 -
  • BIO5 Inspiring Women in STEM
            Jul 12, 2025 - Tucson
  • 2025 KEYS Research Showcase
            Jul 18, 2025 -
  • AZBio Summer Reception at Roche Tissue Diagnostics
            Aug 21, 2025 - Oro Valley
  • 2025 Arizona Alzheimer’s Consortium Scientific Conference
            Sep 4, 2025 - Tempe
  • The MedTech Conference
            Oct 5, 2025 - San Diego
  • 2025 Cell & Gene Meeting on the Mesa
            Oct 6, 2025 - Phoenix
  • 2025 SEMICON WEST
            Oct 7, 2025 - Phoenix
  • Arizona Bioscience Week
            Oct 13, 2025 -
  • The 21st annual AZBio Awards
            Oct 15, 2025 - Phoenix
  • AZAdvances Health Innovation Summit
            Oct 16, 2025 - Scottsdale
  • AZBio Winter Reception at the Flinn Foundation
            Nov 20, 2025 - Phoenix
  • all events

Blog Archive

  • Click the image for the latest news about AZBio Members
  • Click the image to learn more about AZBio Membership
  • Click the image to learn more
  • Click the image to learn more
  • Click the image to learn more
  • Click the image to enter the AZBio Career Center 
  • Patients are why we do what we do. Click the image to listen to their stories.

Disclaimer
Imprint
Cookie Policy (CA)
Privacy Policy (CA)

Copyright 2025 | Arizona Bioindustry Association, Inc.
A SiteOrigin Theme
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}